Understanding and Improving Long-term Outcomes after Sepsis and COVID-19 (Session 11 – 4th WSC)
Understanding and Improving Long-term Outcomes after Sepsis and COVID-19 (Session 11 – 4th WSC)
Session 11 from the 4th World Sepsis Congress. To go directly to a specific speaker/talk, please use these chapter markers:00:00 Intro
00:34 Imrana Malik – Introduction
01:26 Jamie Rylance – The Burden of Long-term Consequences of Sepsis and COVID-19
19:33 Joost Wiersinga – What Is Known on the Pathogenesis of Long-Term Sequelae by Infections and Sepsis?
36:25 Erin Carlton – Toward Tailored Care for Sepsis Survivors
52:00 Hallie Prescott – How Can We Mitigate Post-Sepsis and Post-COVID-Morbidity
1:04:25 Stephanie Taylor – Translating Post-Sepsis Care to Post–COVID-19 Care – The Role of Healthcare Systems
All talks are also available as a podcast – just search for World Sepsis Congress in your podcast app of choice.
Direct link: https://podcasts.apple.com/us/podcast/4th-world-sepsis-congress/id1155062518
Session 12 will be available momentarily. Sessions 13 and 14 will follow on June 13, 2023. The full release schedule is available at https://www.worldsepsiscongress.org/watch
Thanks for watching and sharing.
The 4th World Sepsis Congress – One Global Health Threat: Sepsis, Pandemics, and Antimicrobial Resistance is a project by the Global Sepsis Alliance, initiator of World Sepsis Day and World Sepsis Congress.
Stop Sepsis – Save Lives
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.